Treatment of High Risk Adult Acute Lymphoblastic LeukemiaTolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma.Treatment of Primary CNS LymphomaTherapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and LymphomaCombination Chemotherapy in Treating Young Patients With Acute Lymphoblastic LeukemiaA Study of Children With Refractory or Relapsed ALLTherapy for Pediatric Relapsed or Refractory Acute Lymphoblastic LeukemiaCombination Chemotherapy in Treating Adults With Acute Lymphocytic LeukemiaIfosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's LymphomaCombination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
P4844
Structural studies of several clinically important oncology drugs in complex with human serum albuminPreparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.A cremophor-free self-microemulsified delivery system for intravenous injection of teniposide: evaluation in vitro and in vivoDNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux-an LXR-dependent mechanism.Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells.Reversal of multidrug resistance by mitochondrial targeted self-assembled nanocarrier based on stearylamine.A self-assembled nanocarrier loading teniposide improves the oral delivery and drug concentration in tumor.Molecular cytogenetic evaluation of the aneugenic effects of teniposide in somatic and germinal cells of male mice
P921
Q64139680-CB2021F2-8952-4FC4-99D4-9F0C97B4F845Q64221360-5F26E236-A245-4CAF-9339-C47CA1E53E44Q64353309-09B2404C-F3BE-4D4D-AC1B-455A35CC9968Q64640523-1ADDBD96-2D59-47DE-848D-F526BA1B9E35Q65389236-B90B0FA1-65D3-4CA8-8D67-8C678108C042Q66024718-86E90B04-F718-4254-A824-B0AF8E853D11Q66024735-4BA70956-359E-4BE2-9570-E8941ADC4661Q66035165-3C11A664-2FA4-49DC-8F33-305DAEF59E05Q66036349-578A89BB-9BBA-403B-AE5F-A05FDF2C894BQ66037808-BD3C0C83-988C-4D47-9449-79EBC029AA67
P4844
Q27685192-4DE67DA8-EA74-4DB5-B2F3-D8D624BFA60DQ34356737-F9F7AE02-32EA-4F8E-89C0-79F493745C21Q36195154-35FA3A49-A0E6-412F-AD00-97E74D7D8089Q43451180-3807F292-63F7-4DCA-A0A0-B45CB9CCCD0CQ43495742-F0DF646D-C9CE-46AA-B851-D48DBBB9D869Q43586777-774371BD-DBE1-4505-AC90-53C527BF5BEFQ46127160-6DFF420C-3A1A-4C2D-BB97-E396B18BA5F3Q84707818-AEC28D5C-B4C3-481D-86CC-714D211988C4
P921
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Teniposid
@de
Teniposide
@it
Teniposide
@nl
Teniposide
@vi
Teniposidi
@fi
Tenipozid
@ro
Tenipozid
@sh
Tenipósido
@es
teniposid
@cy
teniposid
@nn
type
label
Teniposid
@de
Teniposide
@it
Teniposide
@nl
Teniposide
@vi
Teniposidi
@fi
Tenipozid
@ro
Tenipozid
@sh
Tenipósido
@es
teniposid
@cy
teniposid
@nn
altLabel
4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)
@en
C32H32O13S
@it
Epidophyllotoxin
@en
Teniposid
@en
Teniposide
@en
Teniposido
@en
Teniposido
@es
Teniposidum
@en
Téniposide
@en
VM-26
@cy
prefLabel
Teniposid
@de
Teniposide
@it
Teniposide
@nl
Teniposide
@vi
Teniposidi
@fi
Tenipozid
@ro
Tenipozid
@sh
Tenipósido
@es
teniposid
@cy
teniposid
@nn